Donald Smith & Co., Inc. filed a Schedule 13G reporting beneficial ownership of 1,149,374 shares, or 4.1% of the common stock of Universal Insurance Holdings, Inc. as of 12/31/2025. The filing is made on a passive basis, stating the shares were acquired and are held in the ordinary course of business, without the purpose or effect of changing or influencing control of the company.
Universal Insurance Holdings, Inc. reported that its Board of Directors declared a cash dividend of $0.16 per share on the company’s common stock. The dividend will be paid on March 13, 2026 to shareholders who are on record as of the close of business on March 6, 2026.
Universal Insurance Holdings, Inc. reported that its Board of Directors has authorized a new share repurchase program. Under this authorization, the Company may repurchase up to $20 million of its outstanding common stock through January 8, 2028. This program allows the Company to buy back its own shares over time, which can reduce the number of shares in the market and concentrate ownership among remaining shareholders. Details of the program were also described in a press release referenced as an exhibit.
Universal Insurance Holdings director reports a small insider sale. A director of Universal Insurance Holdings, Inc. (UVE) reported selling 1,855 shares of common stock on 12/30/2025 at a price of $33.61 per share. The transaction was coded as a sale and was carried out indirectly through The RDP Revocable Trust dated August 11, 2011, of which the director is the grantor and sole trustee and whose beneficiaries are the director's children. Following this sale, the director beneficially owns 8,319 shares indirectly through the trust and 19,136 shares directly.
Universal Insurance Holdings, Inc. CEO and director Stephen Donaghy reported open-market sales of company stock. On 12/29/2025, he sold 25,000 shares of common stock at a weighted average price of $34.07 per share, leaving him with 679,961 shares beneficially owned. On 12/30/2025, he sold an additional 25,000 shares at a weighted average price of $33.77 per share, after which he held 654,961 shares directly. The prices reflect multiple trades within narrow ranges on each day, and the reporting person has committed to provide full trade-by-trade detail upon request.
Universal Insurance Holdings, Inc. insider Sean P. Downes, a director and Executive Chairman, reported gifts of company common stock on 12/30/2025. The transactions were coded as gifts at a reported price of $0 per share.
Following these transactions, he directly beneficially owned 1,198,512 shares of common stock. He also reported indirect ownership of 48,000 shares held by his children and 2,000 shares held by his spouse.
An affiliate of UVE has filed a notice under Rule 144 to potentially sell up to 1,855 shares of common stock through J.P. Morgan Securities LLC on the NYSE, with an approximate sale date of 12/30/2025. The planned sale has an indicated aggregate market value of 63,330.
The shares to be sold were acquired on 12/09/2019 via a stock option exercise from the issuer, paid in cash on the same date. The table also reports that 28,048,881 shares of this class were outstanding; this is a baseline figure, not the amount being sold. By signing the notice, the seller represents they are not aware of any undisclosed material adverse information about the issuer’s current or prospective operations.
A holder of UVE common stock filed an amended notice under Rule 144 to sell 25,000 shares through Wells Fargo Clearing Services on or about 12/30/2025 on the NYSE, with an aggregate market value of $844,398.16. The filing notes that 28,048,881 shares of the same class were outstanding. It also reports that the Stephen Donaghy Trust previously sold 25,000 common shares of UVE on 12/29/2025 for gross proceeds of $851,779.94. The seller represents that they do not know of any material adverse, non‑public information about the issuer’s current or prospective operations.
A shareholder identified as the Stephen Donaghy Trust has filed a Form 144 notice relating to common shares of UVE. The filing covers an intended sale of 25,000 common shares through Wells Fargo Clearing Services on the NYSE around 12/30/2025, with an aggregate market value of 844,398.16. These 25,000 shares were originally acquired on 11/15/2018 via an open market purchase paid in cash. The notice also reports that the Stephen Donaghy Trust sold 25,000 common shares of UVE on 12/29/2025 for gross proceeds of 851,779.94. By signing, the seller represents that they are not aware of any undisclosed material adverse information about UVE’s operations.
A shareholder of UVE has filed a notice of proposed sale of 25,000 shares of common stock under Rule 144. The shares are expected to be sold on the NYSE through Wells Fargo Clearing Services, with an indicated aggregate market value of $851,779.94. The filing notes that 28,048,881 shares of this class were outstanding.
The securities to be sold were originally acquired on 11/15/2018 in an open market purchase paid in cash. By signing the notice, the seller represents that they do not know of any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed, consistent with Rule 144 requirements.